Prospera Financial Services’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Prospera Financial Services’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-31,262	Closed	-$580K	–	1130
2023 Q3	$580K	Sell	31,262 -3,505	-10%	-$39.6K	0.02%	563
2023 Q2	$384K	Buy	34,767 +3,085	+10%	+$43K	0.01%	695
2023 Q1	$425K	Sell	31,682 -124	-0.4%	-$2.15K	0.02%	665
2022 Q4	$393K	Buy	31,806 +2,916	+10%	+$41.3K	0.02%	601
2022 Q3	$403K	Buy	28,890 +3,730	+15%	+$60.1K	0.02%	581
2022 Q2	$347K	Sell	25,160 -873	-3%	-$14K	0.02%	597
2022 Q1	$424K	Buy	26,033 +5,565	+27%	+$87.2K	0.02%	643
2021 Q4	$333K	Buy	20,468 +515	+3%	+$8.68K	0.01%	682
2021 Q3	$296K	Buy	19,953 +6,267	+46%	+$100K	0.01%	664
2021 Q2	$273K	Buy	+13,686	New	+$271K	0.01%	685
2020 Q4	–	Sell	-683	Closed	-$28K	–	1654
2020 Q3	$28K	Buy	+683	New	+$31.4K	0.01%	805

Prospera Financial Services's ICPT Position: Q4 2023 in Review

Prospera Financial Services sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 31,262 shares — an estimated $580K sold.

Prospera Financial Services first reported a position in ICPT in Q3 2020 and held it in 11 quarters. The position peaked at $580K in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

Prospera Financial Services reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
Prospera Financial Services sold 31,262 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $580K.
Prospera Financial Services first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2020 and held it in 11 quarters.
Prospera Financial Services's Intercept Pharmaceuticals, Inc. position peaked at $580K in Q3 2023.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Prospera Financial Services's 13F filing for Q4 2023, filed 14 Feb 2024.